Luca Marsili is a Neurology physician affiliated with University of Cincinnati. OpenAlex indexes 154 publications with 4,312 citations (h-index 36).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3113 Bellevue Ave
Cincinnati, OH 452193158
Telephone
513-475-8730Provider last certified this registry record 12 Jul 2024.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mirum Pharmaceuticals, Inc.Program year20252 payments
- Amneal Pharmaceuticals LLCProgram year20258 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.3%Aromatic Amino Acid Decarboxylation Inhibitor51.9%Carbidopa-Levodopa76%Carbidopa-Levodopa Er16%Rytary9%Part D≥162 patientsCholinesterase Inhibitor10.7%Rivastigmine86%Donepezil Hcl14%Part D<11 patients+ 12 more classes in this area
Cardiovascular
3.1%alpha-Adrenergic Agonist2.2%Midodrine Hcl100%Part D≥13 patientsBeta blocker0.9%Propranolol Hcl100%Part D<11 patientsMusculoskeletal
1.6%gamma-Aminobutyric Acid-ergic Agonist1.6%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
npj Parkinson s Disease
2023 - Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias
The American Journal of Human Genetics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Alberto Espay, MD
University of Cincinnati
Henry Nasrallah, MD
University of Cincinnati
Elyse Lower, MD
University of Cincinnati
Ahmad Sedaghat, MD, PhD
University of Cincinnati
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”